257 related articles for article (PubMed ID: 24103464)
1. Synthesis, characterization and in vitro studies of celecoxib-loaded poly(ortho ester) nanoparticles targeted for intraocular drug delivery.
Palamoor M; Jablonski MM
Colloids Surf B Biointerfaces; 2013 Dec; 112():474-82. PubMed ID: 24103464
[TBL] [Abstract][Full Text] [Related]
2. High celecoxib-loaded nanoparticles prepared by a vibrating nozzle device.
Zvonar A; Kristl J; Kerc J; Grabnar PA
J Microencapsul; 2009 Dec; 26(8):748-59. PubMed ID: 19888883
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release.
Ibrahim MM; Abd-Elgawad AE; Soliman OA; Jablonski MM
J Pharm Sci; 2013 Mar; 102(3):1036-53. PubMed ID: 23293035
[TBL] [Abstract][Full Text] [Related]
4. Poly(ortho ester) nanoparticle-based targeted intraocular therapy for controlled release of hydrophilic molecules.
Palamoor M; Jablonski MM
Mol Pharm; 2013 Feb; 10(2):701-8. PubMed ID: 23256649
[TBL] [Abstract][Full Text] [Related]
5. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats.
Ghorab DM; Amin MM; Khowessah OM; Tadros MI
Drug Deliv; 2011; 18(7):523-35. PubMed ID: 21793779
[TBL] [Abstract][Full Text] [Related]
6. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
7. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
8. Effect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticles.
Cooper DL; Harirforoosh S
PLoS One; 2014; 9(12):e113558. PubMed ID: 25502102
[TBL] [Abstract][Full Text] [Related]
9. Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes.
Amrite A; Pugazhenthi V; Cheruvu N; Kompella U
Expert Opin Drug Deliv; 2010 May; 7(5):631-45. PubMed ID: 20205602
[TBL] [Abstract][Full Text] [Related]
10. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
Song WH; Yeom DW; Lee DH; Lee KM; Yoo HJ; Chae BR; Song SH; Choi YW
Arch Pharm Res; 2014 May; 37(5):626-35. PubMed ID: 23852645
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
Aksungur P; Demirbilek M; Denkbaş EB; Vandervoort J; Ludwig A; Unlü N
J Control Release; 2011 May; 151(3):286-94. PubMed ID: 21241752
[TBL] [Abstract][Full Text] [Related]
12. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Giovino C; Ayensu I; Tetteh J; Boateng JS
Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
[TBL] [Abstract][Full Text] [Related]
14. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines.
Youm I; Youan BB
Hear Res; 2013 Oct; 304():7-19. PubMed ID: 23747541
[TBL] [Abstract][Full Text] [Related]
15. Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation.
Song WH; Park JH; Yeom DW; Ahn BK; Lee KM; Lee SG; Woo HS; Choi YW
Arch Pharm Res; 2013 Jan; 36(1):69-78. PubMed ID: 23325487
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
17. Effect of eye pigmentation on transscleral drug delivery.
Cheruvu NP; Amrite AC; Kompella UB
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110
[TBL] [Abstract][Full Text] [Related]
18. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.
Kim TH; Jeong YI; Jin SG; Pei J; Jung TY; Moon KS; Kim IY; Kang SS; Jung S
Int J Nanomedicine; 2011; 6():2621-31. PubMed ID: 22114493
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
20. Microbeads: a novel multiparticulate drug delivery technology for increasing the solubility and dissolution of celecoxib.
McDonald BF; Coulter IS; Marison IW
Pharm Dev Technol; 2015 Mar; 20(2):211-8. PubMed ID: 24283499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
